RxDoctor Payments Data

Nathan Kroegel

Psychiatric/Mental Health · Draper, UTNPI 1811237514

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 31.5% of the total.

$2,625in general payments, 2019–2025

Across 151 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$827
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$299
  • Tris Pharma Inc$233
  • Takeda Pharmaceuticals U.S.A., Inc.$170
  • Johnson & Johnson$131
  • Lundbeck LLC$120
  • plus $843 from 13 others

What the payments were for

  • Food & beverage$2,625100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,625 in reported general payments places this provider in the 85th percentile of 393 psychiatric/mental health providers in Utah.

See all psychiatric/mental health providers in Utah

Other psychiatric/mental health in Draper

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →